induction of vascular endothelial growth factor expression by sodium arsenite. J Biol Chem 278: 6885–6895. 16. Tokuda H, Hatakeyama D, Shibata T, Akamatsu S, Oiso Y, et al. (2003) p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am J Physiol Endocrinol Metab 284: 1202–1209. 17. Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML (2003) Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278: 5750–5759. 18. Wilmer WA, Dixon CL, Hebert C (2001) Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 60(3): 858–871. 19. Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, et al. (2000) Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase- dependent. Diabetes 49: 655–661. 20. Kang SW, Adler SG, Nast CC, LaPage J, Gu JL, et al. (2001) 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int 59: 1354–1362. 21. Hisayo F, Sayu O, Kenji I, Mariko H, Midori A (2004) ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol 286: 120–126. 22. Kathleen MM (2000) Role of Ras and Mapks in TGFb signaling. Cytokine Growth F R 11: 23–35. 23. Neil AB, Roy Z, Mayshan G, Maureen M, Harold LM (2001) Integrin b1 Signaling Is Necessary for Transforming Growth Factor-b Activation of p38MAPK and Epithelial Plasticity. J Biol Chem 276: 46707–46713. 24. Hughes P, Dragunow M (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47: 133–178. 25. Morgan JI, Curran T (1991) Stimulus-transcription coupling in the nervous system: involvement of the inducible protooncogenes fos and jun. Annu Rev Neurosci 14: 421–451. 26. Fatima M, Damien G, Moshe Y (2001) The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378–2389. 27. Wolfram J, Emmanuelle P, Erwin FW (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401–2412. 28. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4: 131–136. 29. Barr´ıa M, Droguett MA, Burgos ME, Ardiles LG, Flores C, et al. (2001) Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 60(4): 1366–1377. 30. Jung-Hee J, Young-Joon S (2005) AP-1 mediates beta-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPKsignaling pathways. Biochem Bioph Res Co 331: 1421–1428. 31. Guo YS, Hellmich MR, Wen XD, Townsend CM, Jr. (2001) Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 276: 22941–22947. 32. Zheng G, Lyons JG, Tan TK, Wang Y, Hsu TT, et al. (2009) Disruption of E- cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175: 580–591. 33. Bode AM, Ma WY, Surh YJ, Dong Z (2001) Inhibition of epidermal growth factor- induced cell transformation and activator protein 1 activation by [6]- Gingerol. Cancer Res 61: 850–853. 34. Nieto MA, Sargent MG, Wilkinson DG, Cooke J (1994) Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Sci 264: 835–839. 35. He´ctor P, David O, Amparo C (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415–428. p38 MAPK in Epithelial-Mesenchymal Transition 36. Alves CC, Carneiro F, Hoefler H, Becker KF (2009) Role of the epithelial- mesenchymal transition regulator Slug in primary human cancers. Front Biosci 14: 3035–3050. 37. Ce´sar C, Mar´ıa PC, Carolina VD, Isidro SG (2007) Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu Rev Genet 41: 41–61. 38. Strutz F, Muller GA (2000) Transdifferentiation comes of age. Nephrol Dial Transpl 15: 1729–1731. 39. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776–1784. 40. Maria PR, Franco F, Laura G, Giacomo DA, Carlo G (2002) Epithelial- mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137–146. 41. Reddy MA, Adler SG, Kim YS, Lanting L, Rossi J, et al. (2002) Interaction of MAPK and 12-lipoxygenase pathway in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 283: F985–F994. 42. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, et al. (2001) Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens 19: 553–559. 43. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, et al. (2000) Induction of VEGF gene transcription by IL-1 beta is mediated through stress- activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32: 1955–1967. 44. Jung YD, Liu W, Reinmuth N, Ahmad SA, Fan F, et al. (2001) Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the p38 mitogen-activated protein kinase pathway. Angiogenesis 49: 155–162. 45. Tokuda H, Hatakeyama D, Shibata T, Akamatsu S, Oiso Y, et al. (2003) p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am J Physiol Endocrinol Metab 284: 1202–1209. 46. Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML (2003) Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278: 5750–5759. 47. Jiri Z, Markus B, Dan L, Yaw-Ching Y, Aldo M, et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-b. P Natl Acad Sci 98: 6686–6691. 48. Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117: 5965–5973. 49. Shiby P, Agnes MR, Hong JL, Yan J, Bandaru S, et al. (2009) Anti-inflammatory action of pterostilbene is mediated through the p38 MAPK pathway in colon cancer cells. Cancer Prev Res 2: 650–657. 50. Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155–166. 51. Palmer HG, Larriba MJ, Garcia JM, Ordonez-Moran P, Pena C, et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10: 917–919. 52. Pena C, Garcia JM, Silva J, Garcia V, Rodriguez R, et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer:Clinico- pathological correlations. Hum Mol Genet 14: 3361–3370. 53. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84–89. 54. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76–83. PLoS ONE | www.plosone.org 12 July 2011 | Volume 6 | Issue 7 | e22806